FIELD: medicine.
SUBSTANCE: invention represents a biologically active composition in the form of an orally disintegrating tablet characterised by the fact that it contains dehydroepiandrosterone (DHEA) as an active component, or its combination with theanine, and inert filling agents: mannitol, sorbitol, maltitol, crospovidone, copovidone, a lubricant, an intensive sweetening agent and a flavouring agent in certain mixture ratio.
EFFECT: composition is stable and has high bioavailability.
4 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ORALLY DISPERSIBLE TABLET OF DEHYDROEPIANDROSTERONE | 2014 |
|
RU2545812C1 |
| NEW THERAPEUTIC COMPOSITION FOR TREATING PAIN SYNDROME ACCOMPANYING SMOOTH MUSCLE SPASM | 2012 |
|
RU2497505C1 |
| DRUG PREPARATION IN FORM OF ORALLY DISPERSIBLE TABLET AND METHOD FOR MAKING DRUG PREPARATION | 2012 |
|
RU2503447C1 |
| NADH COMPOSITION HAVING ANTIOXIDANT PROPERTIES | 2014 |
|
RU2545920C1 |
| BIOLOGICALLY ACTIVE COMPOSITION IN FORM OF LOZENGE | 2015 |
|
RU2613180C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING MENTAL, BEHAVIOUR AND COGNITIVE DISORDERS | 2012 |
|
RU2488388C1 |
| COMBINATION FOR PREVENTION, CORRECTION AND THERAPY OF PAIN RELATED TO NEURODEGENERATION OR ASSOCIATED WITH SOMATOFORM DISORDERS | 2013 |
|
RU2506077C1 |
| KIT FOR APPETITE CONTROL AND BODY WEIGHT NORMALIZATION AND METHOD OF ITS APPLICATION | 2019 |
|
RU2722728C1 |
| COMBINATION FOR CORRECTION OF NEUROLOGIC AND PSYCHOEMOTIONAL STATUS IN CASE OF ORGANIC CNS DISORDERS | 2013 |
|
RU2536270C1 |
| METHOD FOR PRODUCTION OF CLOZAPINE PHARMACEUTICAL COMPOSITION IN FORM OF TABLETS AND PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2441651C1 |
